Potentiating cancer vaccine efficacy in liver cancer

Tagliamonte, M; Petrizzo, A; Mauriello, A; Tornesello, ML; Buonaguro, FM; Buonaguro, L

Buonaguro, L (reprint author), Fdn Pascale IRCCS, Ist Nazl Studio & Cura Tumori, Dept Expt Oncol, Lab Canc Immunoregulat Unit, Naples, Italy.

ONCOIMMUNOLOGY, 2018; 7 (10):

Abstract

Hepatocellular carcinoma (HCC) is the most common liver malignancy with a poor prognosis and an overall 5-year survival rate of approximately 5-6%. Th......

Full Text Link